Ortho Clinical Diagnostics has announced that the Food and Drug Administration (FDA) accepted the company’s Emergency Use Notification (EUN) for the new VITROS SARS-CoV-2 Antigen test, designed to detect active SARS-CoV-2 infection.
Show CommentsClose Comments